Ryan Harrison, Managing Director IMCD South Africa, comments: “For almost 15 years, IMCD South Africa has shown steady growth. As a leading speciality chemical company for the Sub-Saharan Africa market we are focused on bringing added value to our customers and principals. I’m delighted with the acquisition of Siyeza as it solidifies IMCD pharmaceuticals business. It also places us in an ideal position to keep supporting our suppliers’ growth and continue offering solutions to our customers.”
Sungie Moodley, Managing Director Siyeza says: “We are very pleased to become part of the IMCD family and excited about the potential of combining our knowledge of the South African market with IMCD's global reach and strong formulation and technical know-how.”
The company will continue with its present management and staff.
The closing of the transaction is subject to customary regulatory review and is expected in December 2020.
This website uses cookies to improve your user experience
We use cookies for a variety of purposes, such as website functionality and helping target our marketing activities. Click "accept" to accept our cookies. You can change the cookie settings by clicking "change settings".